SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected hand-foot-mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal ...

People fully vaccinated against hepatitis B who are not immunocompromised can expect sustained immunity throughout their ...

B, a new hepatitis vaccine, vs. standard hepatitis B vaccines as a booster in previously vaccinated individuals.

Still, a bout of hepatitis A can last weeks or months, and the worst cases can cause liver damage and even death. Since 1995, ...

The hepatitis A virus (HAV) is one of the main causes of viral hepatitis and is responsible for an estimated 159,000 ...

Health care workers are at higher risk of hepatitis B infection due to occupational exposure to blood and body fluids.

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...

Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.

"Internationally massive hepatitis vaccination campaigns are not recommended but rather limited to the areas with the greatest incidence of the disease, and in this framework massive could mean a ...

Mar. 12, 2025 — Researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and ...

The diagnosis of hepatitis A virus (HAV) infection is based on the detection of anti-HAV IgM. Shortcomings of this serological approach include the persistence of IgM after normalization of liver ...